Examining the use of ICD-9 diagnosis codes for primary immune deficiency diseases in New York state

Journal of Clinical Immunology

Volumn 33, Issue 1, 2013, Pages 40-48

  Resnick, Elena S ^a   Bhatt, Priyanka ^a   Sidi, Peter ^a   Cunningham Rundles, Charlotte ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

Hospitalizations; International classification of disease codes (ICD 9); New York State; Primary immune deficiency (PID); Severe combined immune deficiency (SCID); Wiskott Aldrich Syndrome (WAS)

Indexed keywords

ARTICLE; FACTUAL DATABASE; HOSPITALIZATION; HUMAN; IMMUNE DEFICIENCY; INCIDENCE; INTERNATIONAL CLASSIFICATION OF DISEASES; SEVERE COMBINED IMMUNODEFICIENCY; UNITED STATES; UTILIZATION REVIEW;

DATABASES, FACTUAL; HOSPITALIZATION; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INCIDENCE; INTERNATIONAL CLASSIFICATION OF DISEASES; NEW YORK; SEVERE COMBINED IMMUNODEFICIENCY;

MLCS; MLOWN;

EID: 84876439670     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-012-9773-1     Document Type: Article

References (47)

1. Notarangelo LD, Fischer A, Geha RS, Casanova JL, Chapel H, Conley ME, et al. Primary immunodeficiencies: 2009 update. J Allergy Clin Immunol. 2009;124:1161-78.
2. Bruton OC. Agammaglobulinemia. Pediatrics. 1952;9:722-8.
3. Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood. 2012;119:1650-7.
4. Bellanti JA, Immunology IV. Clinical applications in health and disease. Bethesda: Saunders; 2012.
5. Joshi AY, Iyer VN, Hagan JB, St Sauver JL, Boyce TG. Incidence and temporal trends of primary immunodeficiency: a populationbased cohort study. Mayo Clin Proc. 2009;84:16-22.
6. Stiehm ER, Ochs H, Winkelstein JA. Immunologic disorders in infants and children. 5th ed. Philadelphia: Elsevier Saunders; 2004.
7. Boyle JM, Buckley RH. Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J Clin Immunol. 2007;27:497-502.
8. Samarghitean C, Ortutay C, Vihinen M. Systematic classification of primary immunodeficiencies based on clinical, pathological, and laboratory parameters. J Immunol. 2009;183:7569-75.
9. Yarmohammadi H, Estrella L, Doucette J, Cunningham-Rundles C. Recognizing primary immune deficiency in clinical practice. Clin Vaccine Immunol. 2006;13:329-32.
10. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol. 1999;92:34-48.
11. Fasano MB, Sullivan KE, Sarpong SB, Wood RA, Jones SM, Johns CJ, et al. Sarcoidosis and common variable immunodeficiency. Report of 8 cases and review of the literature. Medicine (Baltimore). 1996;75:251-61.
12. Mechanic LJ, Dikman S, Cunningham-Rundles C. Granulomatous disease in common variable immunodeficiency. Ann Intern Med. 1997;127:613-7.
13. Thickett KM, Kumararatne DS, Banerjee AK, Dudley R, Stableforth DE. Common variable immune deficiency: respiratory manifestations, pulmonary function and high-resolution CT scan findings. QJM. 2002;95:655-62.
14. Chapel H, Lucas M, Lee M, Bjorkander J, Webster D, Grimbacher B, et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood. 2008;112:277-86.
15. Urschel S, Kayikci L, Wintergerst U, Notheis G, Jansson A, Belohradsky BH. Common variable immunodeficiency disorders in children: delayed diagnosis despite typical clinical presentation. J Pediatr. 2009;154:888-94.
16. Grimbacher B, Holland SM, Gallin JI, Greenberg F, Hill SC, Malech HL, et al. Hyper-IgE syndrome with recurrent infections-an autosomal dominant multisystem disorder. N Engl J Med. 1999;340:692-702.
17. Winkelstein JA, Marino MC, Ochs H, Fuleihan R, Scholl PR, Geha R, et al. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine (Baltimore). 2003;82:373-84.
18. Johnston DT, Mehaffey G, Thomas J, Young Jr KR, Wiener H, Li J, et al. Increased frequency of HLA-B44 in recurrent sinopulmonary infections (RESPI). Clin Immunol. 2006;119:346-50.
19. Winkelstein JA, Marino MC, Lederman HM, Jones SM, Sullivan K, Burks AW, et al. X-linked agammaglobulinemia: report on a United States registry of 201 patients. Medicine (Baltimore). 2006;85:193-202.
20. Abuzakouk M, Feighery C. Primary immunodeficiency disorders in the Republic of Ireland: first report of the national registry in children and adults. J Clin Immunol. 2005;25:73-7.
21. Al-Herz W. Primary immunodeficiency disorders in Kuwait: first report from Kuwait National Primary Immunodeficiency Registry (2004-2006). J Clin Immunol. 2008;28:186-93.
22. Carneiro-Sampaio MM, Carbonare SB, Rozentraub RB, de Araujo MN, Riberiro MA, Porto MH. Frequency of selective IgA deficiency among Brazilian blood donors and healthy pregnant women. Allergol Immunopathol (Madr). 1989;17:213-6.
23. Gathmann B, Binder N, Ehl S, Kindle G. The European internetbased patient and research database for primary immunodeficiencies: update 2011. Clin Exp Immunol. 2011;167:479-91.
24. Knerr V, Grimbacher B. Primary immunodeficiency registries. Curr Opin Allergy Clin Immunol. 2007;7:475-80.
25. Leiva LE, Zelazco M, Oleastro M, Carneiro-Sampaio M, Condino-Neto A, Costa-Carvalho BT, et al. Primary immunodeficiency diseases in Latin America: the second report of the LAGID registry. J Clin Immunol. 2007;27:101-8.
26. Plebani A, Soresina A, Rondelli R, Amato GM, Azzari C, Cardinale F, et al. Clinical, immunological, and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia: an Italian multicenter study. Clin Immunol. 2002;104:221-30.
27. Rezaei N, Aghamohammadi A, Moin M, Pourpak Z, Movahedi M, Gharagozlou M, et al. Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: update from the Iranian Primary Immunodeficiency Registry. J Clin Immunol. 2006;26:519-32.
28. Winkelstein JA, Marino MC, Johnston Jr RB, Boyle J, Curnutte J, Gallin JI, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore). 2000;79:155-69.
29. Waltenburg R, Kobrynski L, Reyes M, Bowen S, Khoury MJ. Primary immunodeficiency diseases: practice among primary care providers and awareness among the general public, United States, 2008. Genet Med. 2010;12:792-800.
30. Kirkpatrick P, Riminton S. Primary immunodeficiency diseases in Australia and New Zealand. J Clin Immunol. 2007;27:517-24.
31. SPARCS Database. New York, 2009: SPARCS Database. Available from: http://www.health.state.ny.us/statistics/sparcs/.
32. Perry NW. Empire State Roads. New York Highways Website. http://www.empirestateroads.com/index.html
33. State & County QuickFacts. 2010. Available from: http://quickfacts. census.gov/qfd/states/36000.html
34. Gennery AR. Immunological aspects of 22q11.2 deletion syndrome. Cell Mol Life Sci. 2012;69:17-27.
35. Cunningham-Rundles C, Sidi P, Estrella L, Doucette J. Identifying undiagnosed primary immunodeficiency diseases in minority subjects by using computer sorting of diagnosis codes. J Allergy Clin Immunol. 2004;113:747-55.
36. Derose KP, Gresenz CR, Ringel JS. Understanding disparities in health care access-and reducing them-through a focus on public health. Health Aff (Millwood). 2011;30:1844-51.
37. Mehra A, Sidi P, Doucette J, Estrella L, Rouvelas H, Cunningham-Rundles C. Subspecialty evaluation of chronically ill hospitalized patients with suspected immune defects. Ann Allergy Asthma Immunol. 2007;99:143-50.
38. Estrella L, Foley ME, Cunningham-Rundles C. X-linked agammaglobulinemia in a 10-year-old child: a case study. J Am Acad Nurse Pract. 2007;19:205-11.
39. Griffith LM, Cowan MJ, Kohn DB, Notarangelo LD, Puck JM, Schultz KR, et al. Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: current status and critical needs. J Allergy Clin Immunol. 2008;122:1087-96.
40. Chan K, Puck JM. Development of population-based newborn screening for severe combined immunodeficiency. J Allergy Clin Immunol. 2005;115:391-8.
41. Yee A, De Ravin SS, Elliott E, Ziegler JB. Severe combined immunodeficiency: a national surveillance study. Pediatr Allergy Immunol. 2008;19:298-302.
42. Begue RE, Perrin K. Reduction in gastroenteritis with the use of pentavalent rotavirus vaccine in a primary practice. Pediatrics. 2010;126:e40-5.
43. Sircar KD, Bancroft E, Nguyen DM, Mascola L. Hospitalization of paediatric patients for methicillin-resistant Staphylococcus aureus skin and soft-tissue infection, 1998-2006. Epidemiol Infect. 2010;138:677-82.
44. Jain VD, Moghbeli N, Webb G, Srinivas SK, Elovitz MA, Pare E. Pregnancy in women with congenital heart disease: the impact of a systemic right ventricle. Congenit Heart Dis. 2011;6:147-56.
45. Amari W, Zeringue AL, McDonald JR, Caplan L, Eisen SA, Ranganathan P. Risk of non-melanoma skin cancer in a national cohort of veterans with rheumatoid arthritis. Rheumatology (Oxford) 2011.
46. Jinjuvadia K, Kwan W, Fontana RJ. Searching for a needle in a haystack: use of ICD-9-CM codes in drug-induced liver injury. Am J Gastroenterol. 2007;102:2437-43.
47. Fillit H, Hess G, Hill J, Bonnet P, Toso C. IV immunoglobulin is associated with a reduced risk of Alzheimer disease and related disorders. Neurology. 2009;73:180-5.